Insulet expands Omnipod 5 to four more International markets
Insulet (PODD) announced its revolutionary Omnipod 5 Automated Insulin Delivery System is now available in Australia and will soon be offered ...
Drug Delivery Business5h
Insulet expands Omnipod 5 to more countries, prices $450M offering
Insulet (Nasdaq:PODD) announced today that it made its Omnipod 5 automated insulin delivery system available in several new geographies.
MedTech Dive8d
Dexcom receives warning letter based on FDA inspections of 2 plants
The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...
Drug Delivery Business10d
Real-world data backs Insulet Omnipod 5 in children
A recently published study highlighted the strong performance of the Insulet (Nasdaq:PODD) Omnipod 5 in children and young ...
Dexcom receives FDA warning letter for 2 manufacturing sites
Dexcom, the local maker of continuous glucose monitors, received a warning letter from the Food and Drug Administration last ...
Yahoo Finance22d
The Zacks Analyst Blog Highlights AbbVie, Amgen, Stryker, Dexcom and Medtronic
Noteworthy is Medtronic's FDA-cleared smart insulin pen that integrates glucose sensor data, utilizing AI to personalize insulin dosing. From an investor’s perspective, the healthcare sector ...
Insulet Corporation: Insulet Expands Omnipod 5 to Four More International Markets
The Omnipod 5 Automated Insulin Delivery System is now commercially available in Australia, launching soon in Belgium, Canada, and Switzerland. Insulet Corporation (NASDAQ: PODD) (Insulet or the Compa ...